The University of Washington, Department of Pharmaceutics currently has an outstanding opportunity for a Postdoctoral Research Associate to join our NIAID-funded Targeted Long-acting Combination Anti-Retroviral Therapy (TLC-ART) research program.

The Associate will be a key member of a project team to provide pharmacokinetic modeling support for a coordinated set of formulation development studies that include 1) in vitro assessment of drug release from nanoparticle formulations, 2) disposition kinetics in blood, lymph and tissues across rodents and non-human primate species, and 3) characterization of lymphatic circulatory physiology by novel imaging studies in animal models.

来源：未知